Phase 1b study of the BET protein inhibitor RO6870810 with venetoclax and rituximab in patients with diffuse large B-cell lymphoma
在弥漫性大B细胞淋巴瘤患者中,BET蛋白抑制剂RO6870810联合维奈托克和利妥昔单抗的1b期研究
期刊:Blood Advances
影响因子:7.1
doi:10.1182/bloodadvances.2021004619
Dickinson, Michael; Briones, Javier; Herrera, Alex F; González-Barca, Eva; Ghosh, Nilanjan; Cordoba, Raul; Rutherford, Sarah C; Bournazou, Eirini; Labriola-Tompkins, Emily; Franjkovic, Izolda; Chesne, Evelyne; Brouwer-Visser, Jurriaan; Lechner, Katharina; Brennan, Barbara; Nüesch, Eveline; DeMario, Mark; Rüttinger, Dominik; Kornacker, Martin; Hutchings, Martin